Society ❯ Public Health ❯ Health Disparities

Access to Medications

Marginalized Populations Consumer Advocacy Consumer Awareness Lower-Income Populations

U.S. Spending on GLP‑1 Drugs Rises to $64.9 Billion as Patient Costs Bite

High out‑of‑pocket payments are driving many patients to stop treatment, prompting calls for insurers and lawmakers to curb cost sharing.

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs